| Dr Barry R Fuller, MD | |
|
5477 W Clark Rd, Ypsilanti, MI 48197-1102 | |
| (734) 434-6000 | |
| (734) 434-7005 |
| Full Name | Dr Barry R Fuller |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 30 Years |
| Location | 5477 W Clark Rd, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134182645 | NPI | - | NPPES |
| 4195910 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | 4301075698 (Michigan) | Secondary |
| 207W00000X | Ophthalmology | 4301075698 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forest Health Medical Center | Ypsilanti, MI | Hospital |
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huron Ophthalmology Pc | 3476566654 | 4 |
| Blue Sky Vision Eye Care Pc | 8820065618 | 50 |
News Archive
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment.
› Verified 4 days ago
| Entity Name | Blue Sky Vision Eye Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801977202 PECOS PAC ID: 8820065618 Enrollment ID: O20050225000498 |
News Archive
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment.
› Verified 4 days ago
| Entity Name | Huron Ophthalmology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558324566 PECOS PAC ID: 3476566654 Enrollment ID: O20060712000056 |
News Archive
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barry R Fuller, MD 5477 W Clark Rd, Ypsilanti, MI 48197-1102 Ph: (734) 434-6000 | Dr Barry R Fuller, MD 5477 W Clark Rd, Ypsilanti, MI 48197-1102 Ph: (734) 434-6000 |
News Archive
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment.
› Verified 4 days ago
Joanne Jeean Choi, Ophthalmology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr Rm 4001, Ypsilanti, MI 48197 Phone: 734-712-3980 | |
John P Barletta, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5477 W Clark Rd, Ypsilanti, MI 48197 Phone: 734-434-6000 Fax: 734-434-7005 | |
Dr. Maxwell William Dixon, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5477 W Clark Rd, Ypsilanti, MI 48197 Phone: 734-434-6000 Fax: 734-434-7005 | |
Dr. Donna Judith Tal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6015, Ypsilanti, MI 48197 Phone: 734-434-7400 Fax: 734-434-7323 | |
Dr. Sunita Yedavally, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Huron River Dr, 100, Ypsilanti, MI 48197 Phone: 734-572-1200 Fax: 734-572-9760 | |
Thomas E Kehn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5477 W Clark Rd, Ypsilanti, MI 48197 Phone: 734-434-6000 Fax: 734-434-7005 |